View Single Post
  #4  
Old Mon Apr 5, 2010, 12:03 PM
Birgitta-A Birgitta-A is offline
Member
 
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918
Survival

Hi lotusbud,
As you can read in this article from 2005 "MDS with isolated erythroid lineage dysplasia identifies a subset of truly low-risk patients, whose survival is significantly affected by demographic variables rather than by disease features. The life expectancy of such patients aged 70 years or older is not significantly shorter than that of the general population."

This means that patients with Refractory Anemia that get their dx when they are 70 years or older can live just as long as persons without MDS .
http://jco.ascopubs.org/cgi/content/full/23/30/7594

One year ago I participated in a patient forum for MDS patients in Stockholm and met several RA patients that had had their disease more than 20 years. They only got Aranesp or similar drugs and were symptom free.

The patients in statistical reports are classified into the the group they belonged to at dx even if they will belong to other categories later.
Kind regards
Birgitta-A
71 yo, dx MDS Interm-1 May 2006, transfusion dependent, Desferal and Exjade for iron overload, Neupogen 2 injections/week for low WBCs, asymptomatic.
Birgitta-A
Reply With Quote